Headshot of Mahmoud Maina.

Mahmoud Bukar Maina

Junior group leader
Biomedical Science Research and Training Centre, Yobe State University and the University of Sussex

Mahmoud Bukar Maina holds dual roles as junior group leader at the Biomedical Science Research and Training Centre at Yobe State University in Nigeria and in the neuroscience department at the University of Sussex in the United Kingdom. His team’s research focuses on generating induced pluripotent stem cells from Indigenous African people for open-access biobanking and investigating the molecular mechanisms of tauopathies in the context of African genetic backgrounds.

In his previous work, Maina identified a critical function of tau in the nucleolus, which sparked his ongoing research on the potential role of ancestry-driven rDNA variations in nucleolar dysfunction in tauopathies. With more than a decade of experience in initiatives to strengthen African science, he sits on multiple local and international committees and serves as a science adviser for the Yobe State Government, where he advises various institutions and funders both within and beyond Africa. He has received several recognitions, including the ALBA-FKNE Diversity Prize for the promotion of basic neuroscience and the Royal Society’s Global Talent visa.

From this contributor

Explore more from The Transmitter

Headshots of Yale researchers Yong-Hui Jiang and Jiangbing Zhou.

Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions

Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.

By Natalia Mesa
3 June 2026 | 11 min read

What counts as a ‘naturalistic’ behavior?

Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.

By Paul Middlebrooks
3 June 2026 | 1 min read
Research image of brain cells involved with Amyotrophic lateral sclerosis (ALS) illuminated through genetic tools

Allen Institute sets sights on treatments for five brain diseases

The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.

By Calli McMurray
2 June 2026 | 5 min read